67 related articles for article (PubMed ID: 15160338)
1. Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.
Shirao K; Ohtsu A; Takada H; Mitachi Y; Hirakawa K; Horikoshi N; Okamura T; Hirata K; Saitoh S; Isomoto H; Satoh A
Cancer; 2004 Jun; 100(11):2355-61. PubMed ID: 15160338
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma.
Konno H; Tanaka T; Baba M; Kanai T; Matsumoto K; Kamiya K; Nakamura S
Jpn J Cancer Res; 1999 Apr; 90(4):448-53. PubMed ID: 10363584
[TBL] [Abstract][Full Text] [Related]
3. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.
Okuma Y; Hosomi Y; Miyamoto S; Shibuya M; Okamura T; Hishima T
BMC Cancer; 2016 Feb; 16():156. PubMed ID: 26915359
[TBL] [Abstract][Full Text] [Related]
4. Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report.
Qu FJ; Wu S; Kong Y
World J Gastrointest Oncol; 2023 May; 15(5):902-910. PubMed ID: 37275454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of preoperative chemoradiotherapy with S-1 for advanced rectal cancer: a phase II study.
Ushigome M; Funahashi K; Kaneko T; Kagami S; Yoshida K; Miura Y; Koda T; Nagashima Y; Kurihara A; Terahara A
Rep Pract Oncol Radiother; 2023; 28(1):36-46. PubMed ID: 37122915
[TBL] [Abstract][Full Text] [Related]
6. Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment.
Anaka M; Abdel-Rahman O
Cancer Manag Res; 2022; 14():273-285. PubMed ID: 35115827
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).
Moriwaki T; Sakai Y; Ishida H; Yamamoto Y; Endo S; Kuramochi H; Sato M; Hatachi Y; Bando Y; Maeba T; Ikezawa K; Shimada M; Amagai K; Morimoto M; Kobayashi K; Tsuji A; Nishina T; Hyodo I
Int J Clin Oncol; 2019 Oct; 24(10):1214-1222. PubMed ID: 31089842
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of preoperative chemoradiotherapy with sequential oxaliplatin and irinotecan with S-1 for locally advanced rectal cancer.
Fujikawa H; Toiyama Y; Inoue Y; Omura Y; Ide S; Kitajima T; Yasuda H; Okugawa Y; Okita Y; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Kusunoki M
Oncol Lett; 2019 Apr; 17(4):3930-3936. PubMed ID: 30881510
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis of Changes to Meibomian Gland Morphology Due to S-1 Chemotherapy.
Ohtomo K; Arita R; Shirakawa R; Usui T; Yamashita H; Seto Y; Yamagami S;
Transl Vis Sci Technol; 2018 Nov; 7(6):37. PubMed ID: 30619657
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Cioffi JH; Estes DJ; Florou V; Ardalan B
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29183892
[TBL] [Abstract][Full Text] [Related]
11. Complete Response of Para-Aortic and Lateral Pelvic Lymph Node Recurrence of Rectal Cancer Treated to S-1 Monotherapy.
Miyazawa T; Koide N; Fujita N
World J Oncol; 2013 Feb; 4(1):46-49. PubMed ID: 29147329
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
Li J; Xu R; Xu J; Denda T; Ikejiri K; Shen L; Toh Y; Shimada K; Kato T; Sakai K; Yamamoto M; Mishima H; Wang J; Baba H
Cancer Sci; 2017 Oct; 108(10):2045-2051. PubMed ID: 28763145
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer.
Suzuki S; Shimazaki J; Morishita K; Koike N; Harada N; Hayashi T; Suzuki M
Mol Clin Oncol; 2016 Oct; 5(4):391-394. PubMed ID: 27699032
[TBL] [Abstract][Full Text] [Related]
14. Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
Takahashi M; Hasegawa K; Oba M; Saiura A; Arita J; Sakamoto Y; Shinozaki E; Mizunuma N; Matsuyama Y; Kokudo N
Invest New Drugs; 2016 Aug; 34(4):468-73. PubMed ID: 27155613
[TBL] [Abstract][Full Text] [Related]
15. A prospective feasibility study to evaluate neoadjuvant-synchronous S-1 with radiotherapy for locally advanced rectal cancer: A multicentre phase II trial.
Inomata M; Akagi T; Nakajima K; Etoh T; Tahara K; Matsumoto T; Ogawa T; Fujii K; Shiromizu A; Kitano S
Mol Clin Oncol; 2016 Apr; 4(4):510-514. PubMed ID: 27073652
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.
Wang ZQ; Zhang DS; Xu N; Luo DY; Deng YH; Wang FH; Luo HY; Qiu MZ; Li YH; Xu RH
Chin J Cancer; 2016 Jan; 35():8. PubMed ID: 26739998
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of safety and efficacy on first-line S-1 therapy in cancer patients.
Miao Y; Zhan P; Lv T; Song Y
Transl Lung Cancer Res; 2015 Aug; 4(4):487-97. PubMed ID: 26380194
[TBL] [Abstract][Full Text] [Related]
18. A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer.
Kim JH; Zang DY; Chung IJ; Cho SH; Park KU; Oh HS; Lee KH; Lee BH; Kim MJ; Park CK; Han B; Kim HS; Choi DR; Song HH; Jung JY
J Cancer; 2015; 6(10):1041-8. PubMed ID: 26366218
[TBL] [Abstract][Full Text] [Related]
19. A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).
Ishihara S; Matsusaka S; Kondo K; Horie H; Uehara K; Oguchi M; Murofushi K; Ueno M; Mizunuma N; Shinbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Nakajima T; Watanabe T
Radiat Oncol; 2015 Jan; 10():24. PubMed ID: 25612635
[TBL] [Abstract][Full Text] [Related]
20. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
